Evidence map›Paper›PMID 28827419›Full record

ArticleAntimicrobial agents and chemotherapy2017

Antifungal Activity of SCY-078 and Standard Antifungal Agents against 178 Clinical Isolates of Resistant and Susceptible Candida Species.

Wiley A Schell, A M Jones, Katyna Borroto-Esoda, Barbara D Alexander

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Antimicrobial agents and chemotherapy · 2025
    Article
  6. Overcoming antifungal resistance inFrontiers in cellular and infection microbiology · 2025
    Review
  7. Article
  8. Review
  9. Antimicrobial agents and chemotherapy · 2024
    Article
  10. Ibrexafungerp: A narrative overview.Current research in microbial sciences · 2024
    Review
  11. Review
  12. Review
  13. New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  14. Review
  15. Article
  16. Therapeutic Approaches for CombatingCurrent drug targets · 2022
    Review
  17. Frontiers in cellular and infection microbiology · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Wiley A SchellDivision of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
A M JonesComputational Genomics Unit, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.
Katyna Borroto-EsodaScynexis, Inc., Jersey City, New Jersey, USA.
Barbara D AlexanderDivision of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA barbara.alexander@dm.duke.edu.
Duke Medical Center · USNational Institutes of Health · USScynexis (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SCY-078

Indexed as

AnidulafunginAntifungal AgentsCandidaDrug Resistance, FungalEchinocandinsGlycosidesHumansMicrobial Sensitivity TestsTriterpenesVoriconazoleAnidulafunginAntifungal AgentsEchinocandinsGlycosidesibrexafungerpTriterpenesVoriconazoleantifungal agentsantifungal resistanceCandida

Identifiers

PMID28827419
PMCPMC5655100
OpenAlexW2745871749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.